Impotence ointment
March 2, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 1176597 2561071 3795675 1-(-Aminomethylbenzyl)isoquinoline compounds Treatment of proliferating skin diseases with papaverine alkaloids Papaverine thienyl-carboxylates and medicaments containing them Medicated bandage pocket Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions Pressure sensitive adhesive film for medical use Patent #: 4564010 InventorsApplicationNo. 07/020544 filed on 03/02/1987US Classes:514/248, Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos514/307, Isoquinolines (including hydrogenated)514/400, At imidazole ring carbon514/502, Iron514/649, Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain514/947Topical applicationExaminersPrimary: Schenkman, LeonardAttorney, Agent or FirmInternational ClassesA61K 33/26 (20060101)A61K 9/00 (20060101) A61K 47/20 (20060101) A61K 31/135 (20060101) A61K 31/485 (20060101) A61K 31/50 (20060101) AbstractAn ointment for relieving impotence. The ointment generally consists of a primary agent, a carrier, and a base, and is applied directly to the penis. The primary agent is a vasodilator selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine. The carrier is used to assist absorption of the primary agent through the skin around the penis. When the primary agent enters the corpora cavernosa within the penis, it causes dilation of the corpora, resulting in an erection. | |
